BACKGROUND: Molecular lesions in T-cell acute lymphoblastic leukemias affect regulators of cell cycle, proliferation, differentiation, survival and apoptosis in multi-step pathogenic pathways. Full genetic characterization is needed to identify events concurring in the development of these leukemias. DESIGN AND METHODS: We designed a combined interphase fluorescence in situ hybridization strategy to study 25 oncogenes/tumor suppressor genes in T-cell acute lymphoblastic leukemias and applied it in 23 adult patients for whom immunophenotyping, karyotyping, molecular studies, and gene expression profiling data were available. The results were confirmed and integrated with those of multiplex-polymerase chain reaction analysis and gene expression profiling in another 129 adults with T-cell acute lymphoblastic leukemias. RESULTS: The combined hybridization was abnormal in 21/23 patients (91%), and revealed multiple genomic changes in 13 (56%). It found abnormalities known to be associated with T-cell acute lymphoblastic leukemias, i.e. CDKN2A-B/9p21 and GRIK2/6q16 deletions, TCR and TLX3 rearrangements, SIL-TAL1, CALM-AF10, MLL-translocations, del(17)(q12)/NF1 and other cryptic genomic imbalances, i.e. 9q34, 11p, 12p, and 17q11 duplication, del(5)(q35), del(7)(q34), del(9)(q34), del(12)(p13), and del(14)(q11). It revealed new cytogenetic mechanisms for TCRB-driven oncogene activation and C-MYB duplication. In two cases with cryptic del(9)(q34), fluorescence in situ hybridization and reverse transcriptase polymerase chain reaction detected the TAF_INUP214 fusion and gene expression profiling identified a signature characterized by HOXA and NUP214 upregulation and TAF_I, FNBP1, C9orf78, and USP20 down-regulation. Multiplex-polymerase chain reaction analysis and gene expression profiling of 129 further cases found five additional cases of TAF_I-NUP214-positive T-cell acute lymphoblastic leukemia. CONCLUSIONS: Our combined interphase fluorescence in situ hybridization strategy greatly improved the detection of genetic abnormalities in adult T-cell acute lymphoblastic leukemias. It identified new tumor suppressor genes/oncogenes involved in leukemogenesis and highlighted concurrent involvement of genes. The estimated incidence of TAF_I-NUP214, a new recurrent fusion in adult T-cell acute lymphoblastic leukemias, was 4.6% (7/152).
BACKGROUND: Molecular lesions in T-cell acute lymphoblastic leukemias affect regulators of cell cycle, proliferation, differentiation, survival and apoptosis in multi-step pathogenic pathways. Full genetic characterization is needed to identify events concurring in the development of these leukemias. DESIGN AND METHODS: We designed a combined interphase fluorescence in situ hybridization strategy to study 25 oncogenes/tumor suppressor genes in T-cell acute lymphoblastic leukemias and applied it in 23 adult patients for whom immunophenotyping, karyotyping, molecular studies, and gene expression profiling data were available. The results were confirmed and integrated with those of multiplex-polymerase chain reaction analysis and gene expression profiling in another 129 adults with T-cell acute lymphoblastic leukemias. RESULTS: The combined hybridization was abnormal in 21/23 patients (91%), and revealed multiple genomic changes in 13 (56%). It found abnormalities known to be associated with T-cell acute lymphoblastic leukemias, i.e. CDKN2A-B/9p21 and GRIK2/6q16 deletions, TCR and TLX3 rearrangements, SIL-TAL1, CALM-AF10, MLL-translocations, del(17)(q12)/NF1 and other cryptic genomic imbalances, i.e. 9q34, 11p, 12p, and 17q11 duplication, del(5)(q35), del(7)(q34), del(9)(q34), del(12)(p13), and del(14)(q11). It revealed new cytogenetic mechanisms for TCRB-driven oncogene activation and C-MYB duplication. In two cases with cryptic del(9)(q34), fluorescence in situ hybridization and reverse transcriptase polymerase chain reaction detected the TAF_INUP214 fusion and gene expression profiling identified a signature characterized by HOXA and NUP214 upregulation and TAF_I, FNBP1, C9orf78, and USP20 down-regulation. Multiplex-polymerase chain reaction analysis and gene expression profiling of 129 further cases found five additional cases of TAF_I-NUP214-positive T-cell acute lymphoblastic leukemia. CONCLUSIONS: Our combined interphase fluorescence in situ hybridization strategy greatly improved the detection of genetic abnormalities in adult T-cell acute lymphoblastic leukemias. It identified new tumor suppressor genes/oncogenes involved in leukemogenesis and highlighted concurrent involvement of genes. The estimated incidence of TAF_I-NUP214, a new recurrent fusion in adult T-cell acute lymphoblastic leukemias, was 4.6% (7/152).
Authors: J C Strefford; H Worley; K Barber; S Wright; A R M Stewart; H M Robinson; G Bettney; F W van Delft; M G Atherton; T Davies; M Griffiths; S Hing; F M Ross; P Talley; V Saha; A V Moorman; C J Harrison Journal: Oncogene Date: 2007-01-22 Impact factor: 9.867
Authors: Teresa Palomero; Maria Luisa Sulis; Maria Cortina; Pedro J Real; Kelly Barnes; Maria Ciofani; Esther Caparros; Jean Buteau; Kristy Brown; Sherrie L Perkins; Govind Bhagat; Archana M Agarwal; Giuseppe Basso; Mireia Castillo; Satoru Nagase; Carlos Cordon-Cardo; Ramon Parsons; Juan Carlos Zúñiga-Pflücker; Maria Dominguez; Adolfo A Ferrando Journal: Nat Med Date: 2007-09-16 Impact factor: 53.440
Authors: Pieter Van Vlierberghe; Martine van Grotel; Joëlle Tchinda; Charles Lee; H Berna Beverloo; Peter J van der Spek; Andrew Stubbs; Jan Cools; Kyosuke Nagata; Maarten Fornerod; Jessica Buijs-Gladdines; Martin Horstmann; Elisabeth R van Wering; Jean Soulier; Rob Pieters; Jules P P Meijerink Journal: Blood Date: 2008-02-25 Impact factor: 22.113
Authors: Brian V Balgobind; Pieter Van Vlierberghe; Ans M W van den Ouweland; H Berna Beverloo; Joan N R Terlouw-Kromosoeto; Elisabeth R van Wering; Dirk Reinhardt; Martin Horstmann; Gertjan J L Kaspers; Rob Pieters; C Michel Zwaan; Marry M Van den Heuvel-Eibrink; Jules P P Meijerink Journal: Blood Date: 2008-01-02 Impact factor: 22.113
Authors: Adolfo A Ferrando; Donna S Neuberg; Jane Staunton; Mignon L Loh; Christine Huard; Susana C Raimondi; Fred G Behm; Ching Hon Pui; James R Downing; D Gary Gilliland; Eric S Lander; Todd R Golub; A Thomas Look Journal: Cancer Cell Date: 2002-02 Impact factor: 31.743
Authors: Adolfo A Ferrando; Scott A Armstrong; Donna S Neuberg; Stephen E Sallan; Lewis B Silverman; Stanley J Korsmeyer; A Thomas Look Journal: Blood Date: 2003-03-13 Impact factor: 22.113
Authors: Paolo Gorello; Roberta La Starza; Danika Di Giacomo; Monica Messina; Maria Cristina Puzzolo; Barbara Crescenzi; Alessandra Santoro; Sabina Chiaretti; Cristina Mecucci Journal: Haematologica Date: 2010-09-17 Impact factor: 9.941
Authors: Xiaoli Mi; Gabriel Griffin; Winston Lee; Sanjay Patel; Robert Ohgami; Chi Young Ok; Sa Wang; Julia T Geyer; Wenbin Xiao; Mikhail Roshal; Jacqueline S Garcia; Lewis B Silverman; Stephen E Sallan; Jon C Aster; Marian H Harris; Olga K Weinberg Journal: Am J Hematol Date: 2018-09-26 Impact factor: 10.047
Authors: S M Chen; W J Song; Y Z Qin; Z Wang; H Dang; Y Shi; Q He; Q Jiang; H Jiang; X J Huang; Y Y Lai Journal: Zhonghua Xue Ye Xue Za Zhi Date: 2021-06-14
Authors: Liang Zhao; Evgeny A Glazov; Diwakar R Pattabiraman; Faisal Al-Owaidi; Ping Zhang; Matthew A Brown; Paul J Leo; Thomas J Gonda Journal: Nucleic Acids Res Date: 2011-02-11 Impact factor: 16.971
Authors: M Parolini; C Mecucci; C Matteucci; U Giussani; T Intermesoli; M Tosi; A Rambaldi; R Bassan Journal: Blood Cancer J Date: 2014-01-17 Impact factor: 11.037